In the Shadow of the Dragon
China’s vision of its place in the world is evolving fast. For the last fifty years, Western companies have dominated the international marketplace and have generally played by the same rules. But Chinese companies are increasingly determined to compete internationally with established Western multinationals. And while many of us may not have heard of these organizations yet, Western companies already find themselves increasingly challenged head-on, forming new alliances with Chinese partners or being bought outright by Chinese investors.
Strengthened by a large, surprisingly well-educated, low-wage workforce, extensive government support, increased education, and an impressive readiness to adapt with lightning speed, Chinese companies are using revolutionary tactics to take down their competition.
Written from the perspective of how China sees the world and how this vision relates to what is actually happening on the ground inside China, In the Shadow of the Dragon examines important factors involving China’s increasing international expansion. China is already having an important impact in the international world on everything from business to employment and there’s no going back now.
Featuring profiles of key players and eye-opening case studies, In the Shadow of the Dragon provides an in-depth analysis of where Chinese organizations are headed and where they will take the rest of us.
Research Information & Knowledge Hub for additional information on IMD publications
You can also buy the book on Barnes & Nobles, Book Depository, Orell Füssli and Routledge.
Chugai C focuses on the company's future as it celebrates its 100th anniversary in 2025. In 2021, Chugai launched its ambitious 'TOP I 2030' growth strategy, aiming to transition from Japan's top innovator to a global leader. The strategy sets two...
Chugai B examines the pivotal strategic alliance formed in October 2002 between Chugai Pharmaceutical and Swiss giant Roche. Facing constraints in RD funding and global reach, Chugai's President Osamu Nagayama sought a partnership to achieve the f...
Chugai A traces the transformative journey of a leading Japanese biopharmaceutical firm from its founding in 1925 to the early 2000s. Starting with founder Jz Ueno's vision to 'create medicines that benefit society,' the case details the company's...
In a world fractured by rival empires and the rise of protectionist ideologies, Europe remains an exception: a continent of stability, rules and trust. Too often described as a museum of past glories, it has in fact become the most prosperous, equ...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
IMD World Competitiveness Center Report, October 2025
Research Information & Knowledge Hub for additional information on IMD publications